Active Ingredient(s): Cellulose Sodium Phosphate
FDA Approved: * December 28, 1982
Pharm Company: * MISSION PHARMA
Category: Hypercalcaemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Calcibind Overview

Sodium cellulose phosphate is a drug used to treat hypercalcemia and hypercalciuria. It has been used to prevent kidney stones.[1][2] This compound is an ion-exchange resin that can not be absorbed by the body. However, it can be used to restore the normal intestinal calcium absorption. When it is taken orally, it binds strongly to calcium and inhibits its absorption into the blood. From there, inhibition is caused due to the lower intraluminal calcium levels, ...

Read more Calcibind Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Calcibind Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cellulose Sodium Phosphate
  • Powder: 2.5g, 2.5gm/packet, 300gm/bot
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Cellulose Sodium Phosphate or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 June 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA